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ABSTRACT 
 
Ring-opening of cyclic sulfamidates with propargylic sulfonamides yielded substrates for a gold-catalysed 
cyclisation to yield tetrahydropyrazines.  Manipulation of the tetrahydropyrazines, by reduction or using 
multicomponent reactions, yielded piperazine scaffolds in which substitution of the carbon atoms was varied.  Such 
scaffolds may have value in the synthesis of novel screening compounds with lead-like molecular properties.    
Sourcing large numbers of diverse, lead-like small 
molecules is a major challenge in maintaining high 
quality screening collections.
1,2  
This challenge stems both 
from the poor availability of lead-like compounds,
2
 and 
the historically uneven exploration of chemical space by 
synthesis.
3
 As an example, many commercially-available 
screening compounds and bioactive molecules contain a 
piperazine ring (5.4% of the ZINC database and 7.7% of 
the ChEMBL database respectively; Supporting 
Information).  Yet, in the vast majority of these 
compounds, the piperazine ring is isolated and is not 
substituted on any of its carbon atoms.  Such piperazines 
are widely exploited in drug discovery because they allow 
the medicinal chemist to design molecules that may be 
grown in two directions whilst retaining basicity through 
                                                     
1 Krier, M.; Bret, G.; Rognan, D. J. Chem. Inf. Model., 2006, 46, 512. 
2 Nadin, A.; Hattotuwagama, C.; Churcher, I. Angew. Chem. Int. Ed. 
2012, 51, 1114. 
3 Lipkus, A. H.; Yuan, Q.; Lucas, K. A.; Funk, S. A.; Bartelt, W. F.; 
Schenck, R. J.; Trippe, A. J. J. Org. Chem. 2008, 73, 4443. 
appropriate substitution.  As a result, many important 
bioactive small molecules are piperazines, including 13 of 
the 200 best-selling drugs in 2012.
4
   
In this paper, we describe an approach to the synthesis 
of substituted piperazines from pairs of bi-connective
5
 
building blocks (Scheme 1).
6
  Ring-opening of a cyclic 
sulfamidate  1,
7,8
 prepared from the corresponding amino 
alcohol, with a propargylic sulfonamide 2 would yield a 
substrate, 3, for a cyclisation reaction.  Metal-catalysed 
                                                     
4 The structures of the top 200 selling drugs can be downloaded from: 
http://cbc.arizona.edu/njardarson/group: McGrath N. A.; Brichacek M.; 
Njardarson , J. T . J. Chem. Educ. 2010, 87, 1348. 
5 MacLellan, P.; Nelson, A. Chem. Commun. 2013, 2383. 
6 For a recent approach to substituted piperazines, see: Ruider, S. A.; 
Müller, S.; Carreira, E. M. Angew. Chem. Int. Ed. 2013, doi: 
10.1002/anie.201306563. 
7 For a review of the application of cyclic sulfamidates in heterocycle 
synthesis, see: Bower, J. F.; Rujirawanich, J.; Gallagher, T. Org. 
Biomol. Chem. 2010, 8, 1505. 
8 Williams, A. J.; Chakthong, S.; Gray, D.; Lawrence, R. M.; Gallagher, 
T. Org. Lett. 2003, 5, 811. 
cyclisation
9,10
 of the N-Boc- (or N-Cbz-) protected amine 
onto the alkyne would then yield a heterocyclic product 4.  
This synthesis of tetrahydropyrazines 4 from the bi-
connective building blocks 1 and 2 may be classified as a 
bi/bi process
5
 or as an ambiphile
11 
pairing reaction 
sequence.  It was envisaged that the ene-diamine 
functionality might serve as a useful handle for decoration 
to yield small molecules with lead-like
2
 properties.   
 
Scheme 1. Overview of the proposed modular synthetic 
approach.a   
aR = Boc or Cbz; R’ = o- or p-nitrophenylsulfonyl. 
 
 
Table 1. Optimisation of the synthesis of the tetrahydropyrazine 
6aa 
 
entry conditions yield 6a            
/ % 
1 5 mol% Au(PPh3)Cl, 5 mol% AgSbF6, 
dioxane, 100 C, w, 10 min 
98 
2 5 mol% Au(PPh3)Cl, 5 mol% AgSbF6, 
dioxane, 100 C, 3 h 
95 
3 5 mol% Au(PPh3)Cl, 5 mol% AgSbF6, 
CH2Cl2, rt, 16 h
c 
83d 
4 1 mol% Au(IPr)Cl,b 1 mol% AgSbF6, 
dioxane, 100 C, w, 10 min 
97 
aNs = o-nitrophenylsulfonyl. bIPr = 1,3,-Bis(2,6-diisopropylphenyl)-
1,3-dihydro-2H-imidazol-2-ylidene.  cAnalysis of the crude reaction 
mixture by 500 MHz 1H NMR spectroscopy revealed a 85:15 mixture of 
the tetrahydropyrazine 6a and the ketone 7a.  dThe ketone 7a was also 
obtained in 15% yield.   
 
Initially, the cyclisation of the substrate 5a (and 
subsequent double bond isomerisation
10
) was investigated 
                                                     
9 For other similar cyclisations, see: (a) Nicolai, S.; Waser, J. Org. Lett. 
2011, 13, 6324.(b) Han, J.; Xu, B.; Hammond, G. B. J. Am. Chem. Soc. 
2010, 132, 916. 
10 For cyclisations of N-propargyl amides to yield oxazoles, see: (a) 
Hashmi, A. S. K.; Weyrauch, J. P.; Frey, W.; Bats, J. W. Org. Lett. 
2004, 6, 4391; (b) Weyrauch, J. P.; Hashmi, A. S. K.; Schuster, A.; 
Hengst, T.; Schetter, S.; Littmann, A.; Rudolph, M.; Hamzic, M.; Visus, 
J.; Rominger, F.; Frey, W.; Bats, J. W. Chem. Eur. J. 2010, 16, 956. 
11 Rolfe, A.; Samarakoon, T. B.; Hanson, P. R. Org. Lett. 2010, 12, 
1216. 
(Table 1).
12
 With 5 mol% Au(PPh3)Cl and 5 mol% 
AgSbF6
13 
in dioxane at 100 C with microwave 
irradiation, the tetrahydropyrazine 6a was obtained in 
98% yield after 10 min (Table 1, entry 1).  With heating 
at 100 C in dioxane, 6a was obtained in 95% yield, 
although a longer reaction time (3 h) was required (Table 
1, entry 2).  At room temperature in dichloromethane, 6a 
(83%) was accompanied by the ketone 7a (15%) (Table 1, 
entry 3).  Additional experiments demonstrated that the 
ketone 7a is a kinetic product of this reaction, and is a 
competent intermediate in the formation of the 
thermodynamic product, 6a.   Cyclisation was also 
effective with 1 mol% of the N-heterocyclic carbene 
complex
14
 Au(IPr)Cl and 1 mol% AgSbF6, yielding 6a in 
97% yield (Table 1, entry 4).     
 
 Figure 1. Structures of building blocks. Ns = o-
nitrophenylsulfonyl; Ns’ = p-nitrophenylsulfonyl. 
 
A range of building blocks (Figure 1) was prepared to 
allow the investigation of the scope and limitations of the 
cyclisation reaction. The potential substrates 5 were 
prepared by treatment of a propargylic sulfonamide 8 
with sodium hydride in DMF, and reaction with a cyclic 
sulfamidate 9 (Table 2).   
                                                     
12 (a) Li, Z.; Brouwer, C.; He, C. Chem. Rev. 2008, 108, 3239. (b) Ito, 
H.; Harada, T.; Ohmiya, H.; Sawamura, M. Beilstein J. Org. Chem. 
2011, 7, 951. (c) Zhang, Y.; Donahue, J. P.; Li, C.-J. Org. Lett., 2007, 9, 
627. (c) Kang, J.-E.; Kim, H.-B.; Lee, J.-W.; Shin, S. Org. Lett. 2006, 8, 
3537. (d) Müller, T. E.; Grosche, M.; Herdtweck, E.; Pleier, A.-K.; 
Walter, E.; Yan, Y.-K Organometallics 2000, 19, 170. 
13 Teles, J. H.; Brode, S.; Chabanas, M. Angew. Chem. Int. Ed. 1998, 37, 
1415. 
14 Marion, N.; Ramón, R. S.; Nolan, S. P. J. Am. Chem. Soc. 2009, 131, 
448. 
 Table 2. Synthesis and gold-catalysed reactions of alkyne 
substrates (see Figure 2) 
entry building 
blocks 
substratea  
(Methodb, yield) 
Producta 
(Methodb, yield) 
1 8a, 9b 5b (A1, 95%) 6b (B1, 98%) 
2 8a, 9c 5c (A1, 72%) 6c (B1, 90%) 
3 8b, 9d 5d (A1, 70%) 6d (B1, 96%) 
4 8a, 9e 5e (A1, 94%) 6e (B1, 96%) 
5 8b, 9f 5f (A1, 68%) 6f (B1, 36%)c 
6  5f 10 (B2, 81%) 
7 8b, 9f 5g (A2, 74%) 6g (B1, 79%) 
8 8b, 9g 5h (A2, 67%) 6h (B1, 85%) 
9 8b, 9h 5i (A1, 89%) 6i (B1, 92%) 
10 8c, 9a 5j (A1, >98%) 7b (B3, 68%) 
11 8d, 9b 5k (A1, 91%) 7c (B3, 85%) 
12 8e, 9b 5l (A1, 90%) 7d (B3, 46%) 
13 8c, 9i 5m (A1, 83%) 7e (B3, 61%) 
aNs = o-nitrophenylsulfonyl; Ns’ = p-nitrophenylsulfonyl. bMethods: 
A1: 8, NaH (1.1 eq), DMF then 9 then 5 M HCl; A2: 8, NaH (1.1 eq), 
DMF then 9 then 1M citric acid solution; B1: 5 mol% Au(PPh3)Cl, 5 
mol% AgSbF6, dioxane, 100 C; B2: 5 mol% Au(PPh3)Cl, 5 mol% 
AgSbF6, CDCl3, rt; B3: 1 mol% Au(IPr)Cl,
 1 mol% AgSbF6, 2:1 
dioxaneH2O, 120 C, sealed tube (IPr = 1,3,-Bis(2,6-
diisopropylphenyl)-1,3-dihydro-2H-imidazol-2-ylidene).  c10 was also 
obtained in 48% yield. 
 
 
 
Figure 2. Structures of the substrates 5f-g and the products of 
gold-catalysed reactions. aNs = o-nitrophenylsulfonyl; Ns’ = p-
nitrophenylsulfonyl. 
 
The cyclisation substrates 5b-i were treated with 5 
mol% Au(PPh3)Cl and 5 mol% AgSbF6 in dioxane at 100 
C (Table 2 and Figure 2).  Under these conditions, the 
substrates 5b-e and 5g-i cyclised smoothly to give the 
corresponding tetrahydropyrazines in 79-98% yield.  This 
study demonstrated that either a Boc- or a Cbz-protected 
amine is a competent nucleophile in the cyclisation.  
However, 5f possesses two potential nucleophiles – a 
Boc-protected amine and an alcohol – positioned at the 
same distance from the alkyne: at 100 C in dioxane, the 
two possible products, 6f and 10,
15
 were obtained in 36% 
and 48% yield respectively.  The outcome was controlled 
at room temperature, and the dihydrooxacine 10 (81%) 
was the only product observed. 
The reactions of 5j-m could be controlled by using 1 
mol% Au(IPr)Cl and 1 mol% AgSbF6 in 2:1 
dioxaneH2O at 120 C in a sealed tube (entries 10-13, 
Table 2); under these conditions, highly regioselective 
hydration of the alkyne was observed.
16,17
  With the 1,2-
disubstituted alkynes 5j, 5k and 5m, hydration occurred 
distal to the NNs group, which might be explained by the 
intermediacy of a chelated intermediate (Figure 3).
18,19 
 
 
Figure 3. Proposed intermediate in the highly regioselective 
hydration of the 1,2-disubstituted alkynes 5j, 5k and 5m. 
 
The tetrahydropyrazines 6c-d and 6i, and the ketone 
7d, were reduced to the corresponding piperazines by 
treatment with triethylsilane and trifluoroacetic acid 
(Figure 4).  The sense of diastereoselectivity depended on 
the identity of the carbamate protecting group.  With the 
Cbz-protected substrate 6c, the 2,6-trans-disubstituted 
piperazine 11a was obtained predominantly, presumably 
as a result of axial attack of the reducing agent on the 
conformation of the intermediate iminium ion in which 
1,3-strain
20
 is minimized.  The Boc-protected substrates 
6d and 6i yielded predominantly the 2,6-cis-disubstituted 
piperazines 11b and 11c; here, Boc deprotection may 
precede reduction via an alternative reactive 
conformation.  Finally, reductive amination of the 
NHCbz-substituted ketone 7d yielded highly selectively 
the 2,3-cis-disubstituted piperazine 11d. 
                                                     
15 For a base-catalysed cyclisation to give 1,4-oxazines, see: Vandavasi, 
J. K.; Hu, W.-P.; Chen, H.-Y.; Senadi, G. C.; Chen, C.-Y.; Wang, J.-J. 
Org. Lett. 2012, 14, 3134. 
16 In contrast, the reactions of 5j-m, catalysed by 5 mol% Au(PPh3)Cl 
and 5 mol% AgSbF6 in dioxane at 100 C, were not clean.   
17 See also: Hashmi, A. S. K.; Molinari, L.; Rominger, F.; Oeser, T. Eur. 
J. Org. Chem. 2011, 2256. 
18 Tsukano, C.; Yokouchi, S.; Girard, A-L.; Kuribayashi, T.; Sakamoto, 
S.; Enomoto, T.; Takemoto, Y. Org. Biomol. Chem. 2012, 10, 6074. 
19 For a related directing effect, see: Hansmann, M. M.; Rudolph, M.; 
Rominger, F.; Hashmi, S. K. A. Angew Chem. Int. Ed. 2013, 52, 2593. 
20 Hoffmann, R. W. Chem. Rev. 1989, 89, 1841. 
 Figure 4. Products of the reductions of the tetrahydropyrazines 
6 and the ketone 7da,b 
 
aWhere appropriate, the major diastereomeric product is drawn.  
bMethod: TFA (10 eq.), Et3SiH (6 eq.), CH2Cl2, 0 C → rt. 
 
 
Figure 5. Products of the multicomponent reactions of the 
tetrahydropyrazines 6 and the ketone 7ba,b 
 
aWhere appropriate, the major diastereomeric product is drawn.  
bMethod: 1. TFA, CH2Cl2 then evaporate; 2. Benzylisontrile or 2-
morpholinoethylisontrile, EtOH, 0 C.  
 
Multicomponent reactions of the tetrahydropyrazines 
6a and 6i and the NHBoc-substituted ketone 7b were also 
investigated (Figure 5).  In each case, the substrate was 
treated with TFA in dichloromethane, evaporated and 
treated with an isonitrile in ethanol.  The 
tetrahydropyrazines 6a and 6i yielded the differentially-
protected piperazine carboxylic acid derivatives 12a-b.
21
  
The reaction of 6i was highly (>98:<2) diastereoselective; 
the sense of diastereoselectivity may stem from 
minimisation of steric interactions in the product-
                                                     
21 Bowers, M. M.; Carroll, P.; Joullié, M. M.  J. Chem. Soc. Perkin 
Trans. 1 1989, 857. 
determining transition state of the Mumm rearrangement 
(Figure 6).
22
  Finally, the ketone 7b was converted into 
the 1,4-diazepane 13 in 71% yield. 
 
Figure 6. Rationalisation of stereochemical outcome of the 
multicomponent reaction of 6i 
 
 
In summary, we have developed a modular approach 
to the synthesis of lead-like piperazine scaffolds.  The 
approach involves reaction between cyclic sulfamidate 
and propargylic sulfonamide building blocks to yield 
substrates for a gold-catalysed cyclisation reaction.  
Crucially, by variation of the specific building blocks 
used, it was possible to be vary the substitution and 
relative configuration of the piperazine scaffolds 
obtained.  It is envisaged that the approach may be 
exploited in the synthesis of libraries of substitutionally-
diverse piperazines with lead-like molecular properties. 
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